Patient and physician preferences for adjuvant treatment of renal cell carcinoma: A discrete-choice experiment.

Authors

null

Shawna R Calhoun

Merck & Co., Inc., Rahway, NJ

Shawna R Calhoun , Caroline Vass , Kelley Myers , Kentaro Imai , Cooper Bussberg , Rituparna Bhattacharya , Cathy Anne Pinto , Christine Poulos

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 635)

DOI

10.1200/JCO.2023.41.6_suppl.635

Abstract #

635

Poster Bd #

F5

Abstract Disclosures

Similar Posters

Poster

2023 ASCO Genitourinary Cancers Symposium

Heterogeneity in physician and patient preferences for the treatment of renal cell carcinoma: Evidence from latent class analysis.

Heterogeneity in physician and patient preferences for the treatment of renal cell carcinoma: Evidence from latent class analysis.

First Author: Caroline Vass

First Author: Moshe Chaim Ornstein

First Author: Takahiro Osawa

First Author: Naomi B. Haas